PDF) SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized
Embase femelle Mini USB type B embase femelle horizontale DS1104-B60SRS DS1104-B60SRS Connfly Contenu: 1 pc(s) – Conrad Electronic Suisse